Caladrius Biosciences Inc. (CLBS) Gained 7.84% or 0.43 To Price $5.9 On Monday


Caladrius Biosciences Inc. (CLBS) gained 7.84% or 0.43 to $5.9. It is near to 38268 shares traded, which is 136.75% compare to the average total volume 27984. The market cap of CLBS is $57.37 million. The year to date change is 55.68%. The 52 week price range is from $2.63 to $11.65. Price of CLBS have changed 3.80% during last week. It have changed 12.78% over last month, 43.57% over last 3 months, -0.18% over last 6 months and 36.07% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLBS is 5.39. It is -8.64% below current price. The 200-day Moving Averages for CLBS is 4.64. It is -21.36% below current price. The 52-week High is 11.65. It is 97.46% from the current price. The 52-week Low is 2.63. It is -55.42% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CLBS is 1.58 on 2018-08-15. Short % to float is 2.90%. There are some statistics of CLBS. It is has market cap $57.37 million. The share outstanding is 9.73 million. The average volume is 27984. It has 59.45M cash and 359553 in debt. The percent of top 15 Institution holding is 5.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLBS is -31.46%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLBS is -24.83%.


Tags:

Share this post